Phillips 66
PSX
239.33
-3.38
-1.39%
Phillips 66
US · PSX
#204 by market cap
Listed 1970
239.33
-3.38
-1.39%
Periodic snapshot; not a real-time feed.
· 2026-11-20 20:02
✦ Quant Ownership Signal how this is computed
Distributing
- The number of reporting institutions decreased by 4 in the most recent period (2026/Q4).
- Total institutional ownership (as a % of shares) was little changed.
Ownership vs. money flow
AlignedInstitutions trimmed shares last reporting period, and the stock has seen net outflows in main-fund flow over the last 20 trading sessions - the two line up.
Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.
Institutional ownership
- Held by institutions
- 80.14% 0.00pp
- Institutions
- 2,656 -4
- As of
- 2026/Q4 vs. prior period
Holder types
Mutual Fund60.15%
Hedge Fund8.52%
Public Company6.14%
Government Pension Fund1.69%
Private Company1.31%
Sovereign Wealth Fund1.18%
Family Office/Trust0.39%
Insurance Company0.30%
Government0.16%
Bank/Investment Bank0.14%
Other20.16%
Top holders as of 2026-09-30
BlackRock
8.73% · 34.04M sh
Vanguard Capital Management, LLC
7.27% · 28.38M sh
State Street Global Advisors
5.96% · 23.23M sh
Vanguard Portfolio Management, LLC
5.65% · 22.04M sh
Elliott Management Corporation
4.94% · 19.25M sh
Other
67.41%
Geode Capital Management, LLC
2.90% · 11.31M sh
Wells Fargo & Company
2.83% · 11.02M sh
AQR Capital Management
1.62% · 6.33M sh
UBS Asset Management
1.55% · 6.03M sh
BNY Mellon Asset Management
1.14% · 4.45M sh
Wellington Management Group
1.32% · 5.13M sh
Bar length is relative to the largest holder shown here, not to 100% of the company.
Insiders
50 filings tracked · 24 buys · 25 sells
| Name | Role | Stake |
|---|---|---|
| Timothy Roberts | Former Executive Vice President of Midstream & Chemicals | 0.02% |
| Kevin Mitchell | Chief Financial Officer | 0.02% |
| Mark Lashier | Chairperson & CEO | 0.01% |
| John Lowe | Former Independent Director | 0.01% |
| Brian Mandell | Executive Vice President of Marketing & Commercial | 0.01% |
| Glenn Tilton | Former Lead Independent Director | 0.01% |
| Ann Kluppel | Senior Vice President | 0.01% |
| Richard Harbison | Executive Vice President of Refining | 0.01% |
| Gary Adams | Former Independent Director | 0.01% |
| Sigmund Cornelius | Independent Director | 0.01% |
Insider transactions most recent Form 4 filings
| Date | Name | Role | Type | Shares | Price |
|---|---|---|---|---|---|
| 2026-09-15 | Brian Mandell | Executive Vice President of Marketing & Commercial | Derivative Exercise and Sale | -23,400 | $74.70–265.06 |
| 2026-09-09 | Ann Kluppel | Senior Vice President | Other Disposition | -40 | -- |
| 2026-08-11 | Richard Harbison | Executive Vice President of Refining | Derivative Exercise and Sale | -52,100 | $74.70–223.76 |
| 2026-08-10 | Brian Mandell | Executive Vice President of Marketing & Commercial | Derivative Exercise and Sale | -33,300 | $74.70–215.00 |
| 2026-08-09 | Lisa Davis | Independent Director | Open Market Disposition | -1,515 | $207.21–208.99 |
| 2026-08-09 | Ann Kluppel | Senior Vice President | Derivative Exercise and Sale | -7,834 | $89.05–215.00 |
| 2026-07-08 | Kevin Mitchell | Chief Financial Officer | Derivative Exercise and Sale | -11,021 | $94.97–190.03 |
| 2026-05-10 | Kevin Mitchell | Chief Financial Officer | Derivative Exercise and Sale | -30,000 | $94.85–171.56 |
| 2026-05-05 | Kevin Meyers | Independent Director | Open Market Acquisition | +175 | $173.13 |
| 2026-03-31 | Donald Baldridge | Executive Vice President of Midstream & Chemicals | Sale to Issuer | -5,885 | $177.21 |
| 2026-03-29 | Kevin Mitchell | Chief Financial Officer | Derivative Exercise and Sale | -15,629 | $94.97–190.07 |
| 2026-03-16 | Kevin Meyers | Independent Director | Open Market Acquisition | +175 | $173.20 |
| 2026-03-15 | Kevin Meyers | Independent Director | Other Acquisition | +949 | $172.84 |
| 2026-03-15 | Howard Ungerleider | Independent Director | Other Acquisition | +949 | $172.84 |
| 2026-03-12 | Lisa Davis | Independent Director | Open Market Disposition | -3,800 | $174.37 |
| 2026-03-11 | Brian Mandell | Executive Vice President of Marketing & Commercial | Derivative Exercise and Sale | -42,800 | $89.57–169.53 |
| 2026-03-05 | Kevin Meyers | Independent Director | Initial Statement of Beneficial | 0 | -- |
| 2026-03-04 | Kevin Mitchell | Chief Financial Officer | Derivative Exercise and Sale | -21,800 | $94.85–168.22 |
| 2026-02-16 | Donald Baldridge | Executive Vice President of Midstream & Chemicals | Open Market Disposition | -7,500 | $160.00 |
| 2026-02-09 | Mark Lashier | Chairperson & CEO | Other Acquisition | +29,148 | $156.70 |
Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.
Quote time 2026-11-20 20:02:43 · For reference only, not investment advice and not tailored to your situation.
Phillips 66 discussion 0 comments